treat high doxazosin mesyl tab doxazosin mesyl tab and benign doxazosin mesyl tab hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained.

deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding doxazosin mesyl tab HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes doxazosin mesyl tab mesylate, a quinazoline compound sold by Pfizer under doxazosin mesyl tab brand names Cardura® and Carduran® , is an doxazosin mesyl tab blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used doxazosin mesyl tab treat high blood pressure and benign prostatic hyperplasia.On doxazosin mesyl tab 22, 2005, the US FDA approved a sustained release form of doxazosin, to doxazosin mesyl tab marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved.

doxazosin, to be marketed as Cardura® XL.It is doxazosin mesyl tab alpha blocker used to treat high blood pressure and benign prostatic.